AFFiRiS AG
Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you.
2 employees · est. 2003 · Wien, Austria
Immunomic Therapeutics, Inc.
A privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms
26 employees · est. 2005 · Rockville, United States
AFFiRiS AG is the older company (2003 vs 2005); Immunomic Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | AFFiRiS AG | Immunomic Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2003 older | 2005 |
| Headquarters | ||
| Headquarters | Wien, Austria | Rockville, United States |
| Employees | ||
| Employees | 2 | 26 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Unknown | Series Unknown |
| Total Funding | ||
| Total Funding | $47.00M | $78.40M |
| Funding Rounds | ||
| Funding Rounds | 4 | 9 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Neurodegenerative Diseases, Parkinson's Disease, Alzheimer's Disease, Multiple System Atrophy, Dementia With Lewy Bodies, Huntington's Disease, Clinical-stage Biotechnology, SAIT, AFFITOME Technology, Peptide Vaccines, Vienna, Austria, Clinical Trials, Monoclonal Antibody | Immunotherapy, Nucleic Acid, Clinical Stage, UNITE Platform, Cancer, Allergy, Infectious Diseases, Lysosomal Associated Membrane Protein, Vaccines, DNA Vaccines, LAMP Technology, Oncology, Animal Health |
| Website | ||
| Website | affiris.com | immunomix.com |
About AFFiRiS AG
AFFiRiS AG is a clinical-stage biotechnology company based in Austria, founded in 2003. The company's slogan, "Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you," encapsulates their mission to challenge established treatment options for neurode...
About Immunomic Therapeutics, Inc.
Immunomic Therapeutics is a privately-held clinical stage biotechnology company headquartered in the United States. Since its foundation in 2005, the company has been pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigati...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at AFFiRiS AG and Immunomic Therapeutics, Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at AFFiRiS AG and Immunomic Therapeutics... — by email.
Frequently Asked Questions
Compare AFFiRiS AG with someone else
Start typing a company name or domain.